|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.8 TWD | +0.39% |
|
-0.89% | -7.49% |
| 15/03 | TCI GENE Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | TCI GENE Inc. Announces Cash Dividend, Payable on December 06, 2023 | CI |
TCI GENE Inc. announced change of the company's representative of institutional director. Name of the previous position holder: Chen Sung Yuan. Resume of the previous position holder: the acting spokesperson of TCI GENE INC. Name of the new position holder: COUNDE O YANG.
Resume of the new position holder: Head of GDC (Global Discovery Chemistry)-China/Executive Director Novartis Institutes for BioMedical Research. Effective date of the new appointment: September 30, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.49% | 63.93M | |
| -16.99% | 8.55B | |
| +65.23% | 4.24B | |
| -1.63% | 2.54B | |
| -10.68% | 2.44B | |
| -41.76% | 2.35B | |
| -8.53% | 1.89B | |
| -19.29% | 1.55B | |
| -39.61% | 1.23B | |
| +9.54% | 1.13B |
TCI GENE INC. 
